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Introduction
High-dose corticosteroids administered early after infarction cause thin scars, and aneurysms late after infarction (1) (2) (3) . The mechanisms by which steroids promote scar thinning and aneurysm formation are unclear. There are at least three possibilities. Steroids might lessen or weaken the collagen laid down by fibroblasts creating a "weaker" scar, thereby allowing late scar stretch. Previous studies have shown, however, that the composition and amount ofcollagen in mature scars ofsteroid treated and control infarcts are no different (3) . This makes late scar stretch a less likely mechanism of steroid-related aneurysmal dilatation. Because steroids are known to delay collagen deposition in healing infarcts (4) , a second possibility is that steroids lead to a prolonged phase during which "soft" necrotic myocardium thins and dilates. The third possibility is that steroids act solely by promoting the early expansion of freshly necrotic myocardium before collagen deposition begins. Infarct expansion, the thinning and dilatation of freshly infarcted myocardium that begins within the first few hours after transmural infarction, (2) , steroids might contribute to late scar thinning and aneurysmal dilatation by worsening early infarct expansion before collagen deposition begins. The cellular mechanism by which steroids might promote infarct expansion in unknown. There are several possible ways that infarct wall thinning could occur before the resorption of necrotic myocytes. First, necrotic myocytes may rupture or tear, leaving fewer intact myocytes across the wall resulting in wall thinning and cavity dilatation (5, 7) . Another possibility is that necrotic myocytes are stretched so that cell lengthening and thinning account for the infarct wall thinning (8, 9) . A final possibility is that wall thinning is due to a geometric rearrangement or a slippage of necrotic myocyte bundles resulting in fewer myocytes across the wall with little or no change in myocyte dimensions (9-1 1) .
The purpose ofthis study was to examine whether high-dose methylprednisolone administered early after infarction worsens infarct expansion, and ifso, to identify whether myocyte rupture, stretch, or slippage accounts for the increase in expansion. Because steroids also delay collagen deposition (4), we examined whether this delay promoted infarct thinning and cavity dilatation beyond the time that infarct expansion is known to plateau.
Methods
Infarct model. 128 Sprague-Dawley female rats, each weighing 200-250 g, were anesthetized with 35 mg/kg body weight intraperitoneal sodium methohexital. The rats were given intermittent positive pressure ventilation with 95% 02 and 5% CO2. The hearts were exposed through left intercostal thoracotomy, and pericardiotomy was performed. Rats were randomized to undergo either left coronary artery occlusion or sham operation. The chest was then closed and 100,000 U benzathine penicillin i.m. was given. The rats were awake within 30 min after surgery and subsequently maintained on standard rat chow and water ad lib. Both infarct and sham rats were further randomized to two subgroups: one to receive methylprednisolone 50 mg/kg i.p. at 5 min, 3 h, 6 h, and 24 h after coronary occlusion, the other to receive a saline placebo. Animals were sacrificed at two time periods. To assess the effect of methylprednisolone on infarct expansion we sacrificed animals at a time when the severity ofinfarct expansion peaks but before significant collagen deposition has begun. Infarct expansion peaks in severity at 3-5 d after transmural infarction in the rat (12). Fishbein et al. (13) has reported that little or no collagen is seen in the infarct zone until after the third day after infarction in the rat. Considering these findings we chose to sacrifice animals 3 d after operation to assess the effects of methylprednisolone on infarct expansion with little influence from the effect of methylprednisolone on collagen deposition. Masson trichrome staining for collagen was used to confirm the assumption that significant collagen deposition had not occurred at 3 d in either methylprednisolone-treated or saline-treated infarcts.
The second sacrifice time was chosen to examine the possible effect of steroid-induced delayed collagen deposition on infarct thinning and dilatation. For this purpose we chose to sacrifice animals 7 d after infarction. This is a time after the severity of infarct expansion plateaus (5 d) (12) and after significant collagen deposition has begun (4-5 d) (13). Methylprednisolone has also been shown to delay collagen in the infarct zone at 7 d (4). Again, Masson's trichrome staining for collagen was used to confirm in our model these previously reported findings.
Preparation ofthe hearts. At sacrifice the animals were heparinized and then anesthetized with intraperitoneal sodium methohexital. The hearts were rapidly excised and immediately submersed in ice-cold saline. Next the ascending aorta ofeach heart was cannulated with polyethylene tubing placed above the aortic valve and tied in place. The tubing was connected to a manifold and a gravity flow apparatus that permitted a constant perfusion pressure of 70 mmHg. The hearts were then vented with fenestrated polyethylene tubing placed into the left ventricle through the mitral valve via incision into the left atrial appendage. Next each heart was perfused retrograde from the aorta for 30 s with heparinized Krebs-Henseleit bicarbonate buffer solution at 370C so that hearts would spontaneously beat under unloaded conditions. When the coronary sinus effluent was clear of blood, the hearts were next perfused with cold 30 mM KCI to achieve rapid and uniform diastolic arrest. Finally the hearts were perfused with 10% buffered formalin for 20 min. The hearts were kept in cold formalin for 24-48 h and then sliced by hand transversely parallel to the atrioventricular groove in four 2.0-2.5-mm sections from apex to base. The slices were embedded in paraffin, and two 5-M-thick sections were prepared from each slice. One section was stained with hematoxylin-eosin, the other with Masson's trichrome stain to demonstrate collagen.
Data analysis. The histopathology of each section was assessed both qualitatively and quantitatively. The sections were numbered to keep the observer blinded with regard to the experimental group. For all infarct hearts, the infarcted and noninfarcted myocardium was examined for the presence of rupture. Rupture was defined as the presence of torn or disrupted myocytes across the wall. The fractional volume of the infarct zone containing inflammatory cell infiltrate was determined for each infarct heart by area-perimeter analysis (14) . Collagen content of the infarct zone was semiquantitatively graded in six randomly selected hearts from each infarct group according to methods described by Kloner et al. (4) : 0, no collagen deposition; I+, occasional thin bundles (< 5 # thick) of collagen; 2+, occasional thin plus occasional thick bundles of collagen; 3+, numerous thin plus occasional thick bundles of collagen; 4+, numerous thick bundles or wide sheets of collagen.
The degree of edema (intercellular space) in the infarct region was qualitatively assessed histologically for all 3-d infarcts. However, Fishbein et al. (13) report that edema peaks at 24-48 h after infarction in the rat. Three days might therefore be too late to assess differences in edema. Thus, we also chose to quantitatively assess the water content of 24-h infarcts by wet to dry weights in a separate group of methylprednisolone and saline-treated rats with infarcts. 12 Sprague-Dawley rats underwent left coronary ligation; six were treated with methylprednisolone 50 mg/ kg i.p. at 5 min, 3 h, and 6 h after coronary occlusion; the rest were treated with saline. This is the same dose and dose schedule used in the other animals except for omission of the 24-h dose. Animals were sacrificed at 24 h; the hearts were excised and arrested by retroade (15) . All hearts were graded independently and blindly by three observers. Interobserver agreement was good with complete concordance in asesing the presence and severity of expansion. For each heart, total left ventricular volume, left ventricular cavity volume, and infarct volume were determined by serial reconstruction of integrated cross-sectional areas of histologic sections. This was done by projecting the heart sections at 7X magnification onto a digitizing tablet interfaced with a Videoplan image analysis microcomputer (Carl Zeiss, Inc., Thornwood, NY). The left ventricular epicardial and endocardial contours were taced, the infarct region, if present, was delineated, and the specified cross-sectional areas and volumes were calculated. Infarct size was then expressed as a percentage of total left ventricular volume.
Further detailed structural evaluation was performed on the transverse section second down from the base of the heart. This section always contained the infarct region. Left ventricular and right ventricular centers of mass were determined for each section by continuously tracing the left ventricular and right ventricular endocardial contours respectively onto a digitizing tablet (Fig. 1) . The center of mass was calculated by computer algorithm as the mean x and y coordinate of all points within the digitized contour (16) . A radian connecting the right ventricular and left ventricular centers of gravity defined the mid-septum. A radian was drawn from the left ventricular center ofgravity to the epicardial surface of the thinnest locus of the infarct region wall. Measurements of infarct wall thickness were made along the course of this radian. For shamoperated animals, the equivalent infarct region wall thickness was measured along a radian drawn from the left ventricular center of gravity at a rotational angle from the midseptal radian comparable with the average location of the thinnest locus of the infarct region in infarct hearts.
We used the following method to distinguish whether steroids affect infarct thinning by promoting myocyte slippage (a decrease in the number ofcells across the wall), or by promoting cell stretch (thinning and elongation of individual myocytes). The number of myocytes across the wall of the infarct region was counted in randomly selected 3-d hearts (four from sham-operated animals, six from steroid-treated, and six from salinetreated infarct animals). Myocytes were counted along the radian that crossed the area of greatest infarct wall thinning. At this locus a region was selected that contained no inflammatory cells and no myocyte dropout. In this region, all infarcted myocytes were still intact and distinct without visible sarcolemmal disruption. This allowed for easy and reproducible counting of necrotic myocytes. The number of myocytes across the full thickness of left ventricular wall were counted using a light microscope interfaced with a digitizing tablet via a camera lucida. The wall thickness at the site of the cell count was also measured. All counting was performed atamagnification of400X. Agrid reticle eyepiece was used to divide the wall thickness into arbitrary unit lengths of 100
ii. The tablet's LED cursor was tracked transmurally from epicardial to endocardial surface. Each time the cursor light crossed a myocyte, an event counter was triggered. The counts were tabulated such that the number of myocytes per unit width of wall thickness (myocyte density) (17) . Graphical displays of the data, using empirical quantile-quantile plots are shown to convey information about differences between data distributions (18) . For confirmatory testing procedures, the study was viewed as a two-way analysis ofvariance (19) with a two-level drug intervention factor (steroid/ no steroid) and a two-level infarction factor (infarct/no infarct). Covariates such as infarct size, extent of transmurality, and time after infarction were included in the design model. All hypotheses were tested by analysis of the main effects and interaction effects. Regression analysis was used to assess the relationship of stretch and slippage with regional wall thickness changes using a general linear model. A P value of < 0.05 was considered significant. When significant differences were found, comparison between individual groups were made using the Neuman-Keuls multiple range test. Prevalence of expansion between saline-treated and steroid-treated infarcts was assessed by Chi-square analysis (19 (Table I) . No hearts sustained rupture. Histopathologic findings. Table II summarizes the quantitative histologic findings. In saline-treated animals, histologic evaluation at 3 d showed the usual changes ofinfarction including hypereosinophilia of myocytes with intense inflammatory infiltration and myocyte degeneration from the margins toward the center of the infarct (Fig. 4 A) . However methylprednisolonetreated animals showed a marked suppression of inflammatory cells in the infarct zone. At 3 d inflammatory cell infiltration was present in 62.44±2.4% of the infarct area among salinetreated but only 14.28±3.7% of the infarct area among methylprednisolone-treated infarcts (P < 0.001). Among methylprednisolone-treated infarcts, hypereosinophilic myocytes were intact and some myocytes still retained pyknotic nuclei (Fig. 4  B) . These changes are consistent with delayed necrosis and "mummification" previously reported by Bulkley (Table I) . Fig. 5 show the differences in the data distributions for infarct wall thickness and cavity volume between the sham animals and both infarct groups. All animals with infarcts had significantly thinner infarct walls and larger left ventricular cavity volumes than sham-operated animals (P < 0.001). Furthermore, methylprednisolonetreated animals had significantly thinner infarcts than salinetreated animals with infarcts (P < 0.001). Although infarcts in both treated groups underwent thinning, only the more severely expanded infarcts underwent cavity dilatation. The severely expanded infarcts from the methylprednisolone-treated group had markedly larger left ventricular cavities than those from the saline-treated group. Therefore, methylprednisolone increased the severity of infarct expansion with no effect on infarct size or prevalence of expansion.
Effect ofmethylprednisolone on severity ofexpansion during the early healing phase (7 d Myocardial cell slippage vs. stretch. We next examined the possible cellular mechanisms by which methylprednisolone treatment causes early infarct wall thinning. Because no rupture of necrotic myocytes was seen in either group at 3 d, there are two other possible mechanisms by which steroids could promote early infarct expansion. Methylprednisolone might promote the stretch ofnecrotic myocytes in the infarct region. As the myocytes stretch, their fiber diameters decrease without change in number ofcells across the wall resulting in infarct thinning and dilatation. Alternatively, methylprednisolone might increase the slippage of necrotic myocytes, whereby myocytes would slip past one another and rearrange so that fewer myocytes compose the thickness of the infarct wall, thereby resulting in more severe thinning and dilatation. To study this, counts of the number of myocytes across the infarct region were performed in a total of 16 hearts: 4 shams, 6 saline-treated, and 6 methylprednisolonetreated infarcts. The number of myocytes per unit width ofwall thickness (myocyte density) was used as a measure of change in individual myocyte dimension. There was no significant difference in the regional myocyte density across the wall in hearts of the sham group or either infarct group. Myocyte density averaged 5.1±0.1 cells per 100 in sham hearts, and 5.9±0.04 cells per 100 u within the infarct region of the saline-treated infarct group, a difference of 16%. We have previously shown that this increase in myocyte density among hearts with infarcts can be explained by a reduction in myocyte cell diameter (myocyte stretch) (1 1). However, this degree of change in myocyte density does not explain the degree of thinning seen between sham and infarct hearts. Mean infarct wall thickness was 2.7±0.2 mm in the sham group and 1.2±0.1 mm in the saline-treated infarct group a difference of 56%. The 16% increase in myocyte density would account for a -13% reduction in wall thickness. Moreover, no significant difference in myocyte density between methylprednisolone (6.0±0.04) and saline (5.9±0.04) -treated 3-day infarcts was seen. Thus, the difference in infarct wall thinning between methylprednisolone-and saline-treated infarcts by day 3 must occur by a mechanism other than cell stretch. In With regard to myocyte branching we felt our counting method adequately recognized branching myocytes both in crosssectional and longitudinal planes. However even if we overestimated total cell counts through failure to recognize branched myocytes, the differences in cell counts between the groups would not be affected because the branching pattern of myocytes is presumably the same in the control and treatment groups. It would mean however that the determined cell number per 100 ,u wall thickness and the number of myocytes across the wall are overestimates in absolute terms.
Discussion
To study possible early mechanisms of steroid-induced scar thinning and dilatation, we used the rat model of acute myocardial infarction. The rat model has been useful in the study of infarct expansion (1 1) and has been used to study steroidinduced structural changes in the infarct region (1). Methylprednisolone was administered in doses similar to those used lower than the lowest sham value. The next lowest values in the infarct groups were lower than the next lowest in the sham group. A similar comparison between each successive value of each group through to the highest value can be made and in each case the infarct values are less than shams. Also it can be seen that the methylprednisolone group is skewed toward having thinner walls than the salinetreated group. The thinnest infarcts in the methylprednisolone group are much thinner than the thinnest infarct in the saline-treated group. (B) Both infarct groups had significantly larger cavities than the sham group. As with wall thickness, a similar skewing toward extreme values is seen with cavity volumes in the methylprednisolone group compared with the saline group.
by other investigators (1, 3, 4) . Animals were sacrificed to assess the severity of expansion both before (3 d) and after (7 d) early collagen deposition begins. Histochemical studies to confirm these assumptions concerning collagen deposition were performed. We noted no significant collagen staining with Masson's trichrome in the infarct zone of either methylprednisolone-or saline-treated animals at 3 d, suggesting that no significant new collagen deposition had occurred by this time. These findings are in accord with those of Fishbein et al. (13) who also found scant collagen staining by Masson's trichrome in the 3-d-old rat infarct. Therefore effects of steroids on infarct structure by 3 d is likely, independent of effects on collagen deposition. At 7 d, our histochemical results also confirmed findings by Kloner et al. (4) that methylprednisolone-treated animals undergoing infarction have markedly reduced collagen staining in the infarct zone compared with control animals with infarcts. Thus the 7-d time period is appropriate to study the influence of delayed collagen deposition on early aneurysmal dilatation.
The results of this study show that high-dose methylprednisolone administered within the first 24 h after infarction did not change the prevalence ofinfarcts that underwent expansion. By 3 d, however, methylprednisolone markedly aggravated the severity of early infarct expansion without any effect on infarct size. That is, in this study, methylprednisolone did not cause expansion in transmural infarcts that would otherwise not expand. But among infarcts that did expand, expansion was more severe in methylprednisolone-treated hearts. Although methylprednisolone delayed collagen deposition and healing in 7-d infarcts, it caused no further infarct thinning or cavity dilatation beyond the initial 3 d. Therefore, enhanced early infarct expansion before the beginning of collagen deposition appears to be the major component ofsteroid-induced aneurysmal dilatation. This implies that a delay in collagen deposition leading to a prolonged phase during which necrotic myocardium might be more susceptible to thinning and dilatation is not the explanation dominate the infarct. Steroid action on the myocardium at this early time likely relates to its effect on these structural elements within the infarct region. We therefore examined possible cellular mechanisms by which steroids worsen early infarct expansion. Our results show that the entire additional decrease in infarct thickness seen with steroid therapy could be explained by a decrease in transmural myocyte number without evidence of myocyte stretch or myocyte rupture. This implies that infarct thinning occurs by myocyte slippage. These results agree with the findings of other investigators. By counting the number ofmyocytes across the wall and cross-sectional area ofmyocytes, Linzbach et al. (9) showed that ventricular dilatation due to chronic volume overload could not be explained by myocyte stretch but rather by a sliding displacement or slippage of heart layers leading to a decrease in the number of muscle layers in the ventricular wall. Spotnitz et al. (10) also reported a strong correlation between changes in wall thickness and changes in transmural cell number but not cell density when studying rat hearts postmortem, passively distended with varying left ventricular volume. These findings suggested that most of the wall thinning is not mediated by individual myocyte stretch but rather by a change in the geometric arrangement of groups of myocytes perhaps by a sliding between myocyte bundles (slippage). In addition, we have previously shown that the structural changes of infarct expansion are for the most part mediated by the slippage of necrotic myocytes (decrease in the number of cell across the wall) both within and outside the infarct zone (15) .
How do steroids lead to decreased numbers of myocardial fibers across the wall? There are two possibilities. First, steroids might alter the volume load and augment wall stress on the expanded ventricle, resulting in layers of cells slipping apart with aggravated expansion. Although we did not measure hemodynamics, several studies have shown no significant hemodynamic change when high-dose methylprednisolone is administered acutely after infarction (20) (21) (22) (23) . Thus, it is unlikely that steroids alter load significantly enough to independently worsen expansion.
A second possibility is that steroids primarily alter the material properties of the infarcted myocardium leading to worsening cell slippage and further expansion. Caulfield and Borg (24) have suggested that the viscoelastic properties of myocardium are determined by a weblike network of loose collagen around bundles of myocytes. These loose collagen connections between myocyte bundles could permit the slippage and rearrangement of these bundles as seen in acute cardiac dilatation.
Immediately after coronary occlusion, the ischemic segment becomes noncontractile and systolic bulging is seen (25) . Forrester et al. (7) hypothesized that systolic bulging might be caused by passive stretch and ultimate anatomic disruption of noncontractile myocardial fibers and could account for the dilatation of the ischemic segment. However, our analysis showed no significant myocyte stretch and no evidence of myocardial fiber rupture. We postulate instead that the degree to which ischemic myocyte bundles slip determines the extent to which the ischemic zone thins and dilates. Early systolic bulging of ischemic myocardium might then represent the enhanced slippage ofmyocyte bundles to the extent allowed by the loose collagen connections between these bundles.
Systolic bulging of the infarct zone partially but not completely resolves progressively after the first few hours ofischemia and infarction (26). Some hearts, however, particularly those having sustained transmural infarction, remain with a fixed increase in diastolic infarct segment length. This persistent early segmental dilatation of the infarct zone represents infarct expansion. On the cellular level this might represent irreversible myocyte bundle slippage due to overstretch or rupture of the loose collagen connections between these myocyte bundles. In hearts that show partial resolution of systolic bulging, in the early hours after infarction, several investigators have reported a concomitant increase in the local diastolic stiffness ofthe infarct zone (26, 27) . This stiffness continues to increase over the next few days before collagen deposition begins. Thus, this early increase in stiffness that anatomically might represent the resistance to myocyte bundle slippage may be important in limiting the extent of infarct expansion.
Changes in the material properties of the infarcted myocardium could account for the early increase in infarct wall stiffness. Reimer and Jennings (28) have reported that in the early hours after coronary occlusion the infarct region gains weight by the accumulation of edema. Over the next few days the infarct region gains further weight by the addition of cellular elements. The development of edema and subsequent inflammatory cell infiltrate might be the anatomic elements that explain the early increase in stiffness measured in the infarct zone. On the cellular level these components of the interstitial space could buttress the loose collagen network and limit the extent of necrotic myocyte bundle slippage and infarct expansion. Steroids have been shown to suppress tissue edema in the early hours after inflammation (29, 30) . These effects are dose dependent and last for only several hours after they are administered (30) . We have shown that high-dose methylprednisolone completely suppressed the edema in 24-h infarcts. In addition, inflammatory cell infiltration was markedly suppressed at 3 d by methylprednisolone. One could surmise therefore that reduced early edema and decreased inflammatory cell infiltration associated with high-dose steroids could promote myocyte bundle slippage and thus worsen infarct expansion. These results support findings by Hammerman et al. (31) who showed that indomethacin, a nonsteroidal antiinflammatory agent, promoted early infarct expansion in the dog. These authors postulated that suppression ofearly edema by indomethacin promotes expansion. However, because they studied 7-d infarcts they were unable to detect the differences in edema between treatment and control groups that we demonstrated at 24 h.
A possible limitation of our results and assumptions concerning the mechanisms of enhanced infarct expansion by steroids relates to our method ofquantifying collagen in the infarct zone. We recognize that Masson's trichrome stain may not be sensitive enough to detect small amounts of collagen laid down by the rare fibroblasts seen at the margins of 3-d-old infarcts. Thus, it remains to be determined by using more sensitive methods such as hydroxyproline assays whether small amounts of collagen are laid down at the margins or the infarct and whether early steroid treatment affects this deposition. Nevertheless, because at 3 d no fibroblasts are seen throughout most ofthe infarct zone, including the thinnest central region, we believe that an effect by steroids on early collagen deposition, even if demonstrable, would not significantly alter the severity of infarct expansion at this time.
Likewise in 7-d infarcts Masson trichrome stain was again used to assess infarct region collagen content. However, the differences in collagen staining between steroid-and saline-treated animals with 7-d-old infarcts are so dramatic that it is unlikely that these results would be substantially changed by utilizing more precise quantitative methods of assessing collagen content in the infarct zone.
In conclusion, this study shows that high-dose steroids lead to infarct thinning and cavity dilatation within 3 d of infarction and that there is no further effect on infarct expansion after this time. We also showed that steroids promote expansion by enhancing the slippage of necrotic myocytes. Furthermore, steroids were shown to reduce edema content and the inflammatory cell infiltration within the infarct zone during the time when expansion occurs. The steroid enhanced slippage ofnecrotic myocytes focuses attention on the potential importance of the connections between myocyte bundles and also the extracellular matrix in determining the severity of expansion. Edema and inflammatory cell infiltration may be the elements of this extracellular matrix that limit myocyte bundle slippage and hence infarct expansion independent of steroid treatment. Further studies are needed to test these hypotheses and further clarify the mechanisms that determine the severity of expansion.
